✦ LIBER ✦

Inhibitors of Endocannabinoid Degradation: Potential Therapeutics for Neurological Disorders

✍ Scribed by Michaela Wendeler; Thomas Kolter

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 992 KB
Volume: 42
Category: Article
ISSN: 0044-8249
DOI: 10.1002/anie.200301641

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitors of Endocannabinoid Degradatio

Inhibitors of Endocannabinoid Degradation: Potential Therapeutics for Neurological Disorders

✍ Michaela Wendeler; Thomas Kolter 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 53 KB

## Abstract For Abstract see ChemInform Abstract in Full Text.

Therapeutic potential of neurotrophic fa

Therapeutic potential of neurotrophic factors for neurological disorders

✍ Eric C. Yuen; Dr William C. Mobley 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1009 KB

Recent Progress in Development for Dopam

Recent Progress in Development for Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

✍ Ao Zhang; John L. Neumeyer; Ross J. Baldessarini 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB 👁 1 views

ChemInform Abstract: Endoxifen is a New

ChemInform Abstract: Endoxifen is a New Potent Inhibitor of PKC: A Potential Therapeutic Agent for Bipolar Disorder.

✍ Shoukath M. Ali; Ateeq Ahmad; Syed Shahabuddin; Moghis U. Ahmad; Saifuddin Sheik 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

Cellular replacement therapy for neurolo

Cellular replacement therapy for neurologic disorders: potential of genetically engineered cells

✍ Lan S. Chen; Jasodhara Ray; Lisa J. Fisher; Michael D. Kawaja; Malcolm Schinstin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

## Abstract Neural transplantation, a mode of cellular replacement, has been used as a therapeutic trial for Parkinson's disease. Studies indicate that tonic release of the metabolites from the graft that can be utilized by the host brain, is likely to be the major mechanism responsible for the the

From Bench to Bedside: Future Potential

From Bench to Bedside: Future Potential for the Translation of Prolactin Inhibitors as Breast Cancer Therapeutics

✍ Charles V. Clevenger; Jiamao Zheng; Elizabeth M. Jablonski; Traci L. Galbaugh; F 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 225 KB